Prosthetic

‘SUITX by Ottobock’ Sets New Standards in Exoskeleton Technology

New back-support exoskeleton for logistics, new business unit, new umbrella brandEMERYVILLE, CA / ACCESSWIRE / October 12, 2023 / Today…

5 months ago

BioNTX Names Osteal Therapeutics 2023 Rising Star

President and CEO, David Thompson, will present at the upcoming iC³ Life Science Summit alongside fellow Rising Star recipients The award…

6 months ago

Renowned Plastic Surgeon Dr. Lawrence Gray Expands Services to Enhance Aesthetic Beauty and Confidence in Portsmouth, NH

PORTSMOUTH, NH / ACCESSWIRE / September 27, 2023 / Atlantic Plastic Surgery Center is delighted to announce the expansion of…

6 months ago

PHAXIAM Provides Business and Financial Update For the First Half of 2023

PHAXIAM Provides Business and Financial UpdateFor the First Half of 2023 Conference call and webcast (English) on Monday, September 25,…

6 months ago

Osteal Therapeutics Closes $23M Series C Financing

Financing led by Asteroid Partners with new investor Gideon Strategic Partners and returning investors Johnson and Johnson Development Corp., HM…

6 months ago

ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development

YONKERS, New York, Sept. 19, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the…

6 months ago

Thought Leadership & Innovation Foundation (TLI) Showcases Data-Driven Healthcare Solutions at 2023 AOPA National Assembly

MCLEAN, Va.--(BUSINESS WIRE)--Thought Leadership & Innovation Foundation (TLI), a not-for-profit organization that works at the nexus of science, technology and…

7 months ago

ContraFect to Present at the World Anti-Microbial Resistance Congress 2023

YONKERS, N.Y., Aug. 28, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery…

7 months ago

ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update

YONKERS, N.Y., Aug. 14, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery…

7 months ago

Signati™️ Medical, Inc. Announces Dr. LeRoy Jones Has Been Appointed to Its Board of Directors

Providence, RI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Signati™️ Medical, Inc. announced today that Dr. LeRoy Jones has been appointed…

8 months ago